- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05450146
Trial-based Effectiveness and Cost-effectiveness of the Partner in Balance Intervention
Trial-based Effectiveness and Cost-effectiveness of the Partner in Balance Intervention to Selfmanage Mild Dementia Via Blended eHealth Psycho-education and Behavioural Modelling for the Care Partner Coached by a Case Manager
Rationale:
Informal care is one of the most important sources of care for dependent elderly people. The Partner in Balance (PIB) intervention aims to prepare and support informal caregivers for their caregiving tasks. Long-term cost-effectiveness evidence is required to support reimbursement decision-making on this PIB program. The investigators hypothesize that 1) caregiver self-efficacy in intervention arm PiB is higher compared to the control arm of usual care; 2) care costs of participants in intervention arm are lower compared to the control arm of usual care.
Objectives:
The investigators aim to answer the following research questions:
- What is the effect of PiB on caregiver self-efficacy compared to usual care?
- What is the effect of PiB on caregiver and person with dementia total care costs compared to usual care?
- What is the incremental cost-utility ratio of PiB compared to usual care?
- What is the annual budget impact of PiB compared to usual care?
Study design:
Pragmatic, cluster randomised controlled trial.
Study population:
Informal caregivers of people with early-stage dementia who are community-dwelling and are receiving little or no dementia-related formal ADL-care
Intervention: blended E-health informal caregiver support program with online psycho-education and behavioural modelling. It contains personalized goal setting, online modules with option for online communication with care professional, evaluation with care professional.
Main study parameters/endpoints:
Primary: self-efficacy. Cost-utility: EQ5D, RUD. Secondary: quality-of-life, caregiver burden
Data collection:
Measurements consist of questionnaires (total duration is approximately 1 hour; administered at home, via telephone, via email or other location if preferred by the participant; take place at baseline, 3, 6, 12 and 24 months).
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sander Osstyn, MSc
- Phone Number: +31 43 388 1137
- Email: s.osstyn@maastrichtuniversity.nl
Study Contact Backup
- Name: Ron Handels, PhD
- Phone Number: +31 43 38 81036
- Email: ron.handels@maastrichtuniversity.nl
Study Locations
-
-
Limburg
-
Maastricht, Limburg, Netherlands, 6221
- Recruiting
- Alzheimer Centrum Limburg
-
Contact:
- Sander Osstyn, MSc
- Phone Number: +31 43 388 1137
- Email: s.osstyn@maastrichtuniversity.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subject is an informal caregiver of a person with early stage dementia.
- The caregiver provides support for a person with dementia who is diagnosed of dementia (self-reported or known by the recruiting organization) or underdiagnosed dementia (no formal diagnosis but symptoms of dementia)
- The caregiver provides support for a person with dementia who is not yet receiving formal care related to personal activities of daily living on account of his/her dementia more than two times a week (defined by receiving assistance from a paid worker by e.g., health or social care such as help with dressing/undressing, washing/bathing/showering, toileting, feeding/drinking, taking medication or attending day activity or day care centre).
Exclusion Criteria:
- The informal caregiver is participating in another trial with similar objectives as this research.
- The informal caregiver has a major mental or physical illness
- The informal caregivers' person with dementia has a major mental or physical illness.
- The dementia of the informal caregivers' person with dementia is caused by human immunodeficiency virus (HIV), acquired brain impairment, Down syndrome, chorea associated with Huntington's disease, or alcohol abuse.
- Informal caregiver is younger than 18 years old.
- Informal caregiver or person with dementia does not have a minimum understanding of Dutch language.
- Informal caregiver has no basic internet skills.
- Informal caregiver has no access to internet at home.
- Informal caregiver has not received the online cursus 'Partner in Balance' yet.
- Informal caregiver is not receiving a similar support program.
- The informal caregiver is not able to follow COVID19 instructions. Type of dementia (e.g., Alzheimer, vascular) will not be a selection criterion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Partner in Balance (intervention group)
Informal caregivers assigned to the intervention group will receive the 8-week online selfmanagement program "Partner in Balance" (Boots, 2018).
|
The "Partner in Balance" intervention (Boots, 2018) consists of 1) a face-to-face intake session with a care professional (casemanagers, dementia nurses or district nurses) to familiarize participants with the program, set goals, and select preferred module themes; 2) tailored online thematic modules, including psychoeducation, behavioral modeling, reflective assignments, set goals, and online messaging feedback with the care professional over 8 weeks; and 3) a face-to-face evaluation session with the care professional evaluating previously set goals.
|
|
No Intervention: Usual/standard care (control group)
Participants in the comparison condition will continue to receive the care as usual. The control group will be shared with another collaborating study from the 'Vrije Universiteit of Amsterdam'), which has the same goals, applies the same inclusion criteria, applies the same study procedures, and obtains the same outcomes. This implies that the data of the participants recruited for the control group for this study will be shared with the collaborating study. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-efficacy
Time Frame: 24 months
|
The self-efficacy of informal caregivers measured by the Caregiver Self-efficacy Scale (CSES) (Fortinsky, 2002).
The maximum and minimum answer scores range from 1 to 10 with higher scores indicating better outcomes.
|
24 months
|
|
Health-related quality-of-life
Time Frame: 24 months
|
Health-related quality-of-life of the informal caregivers and persons with dementia measured by the EQ-5D-5L.
The questionnaire is scored on a 5-point Likert scale.
|
24 months
|
|
Healthcare resource use
Time Frame: 24 months
|
Healthcare resource use of the informal caregivers and persons with dementia measured by the Resource Utilization in Dementia (RUD) (Wimo, 2013).
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression and anxiety
Time Frame: 12 months
|
Depression and anxiety of informal caregivers measured by the Hospital and Anxiety Depression Scale (HADS) (Bjelland, 2002).
The questionnaire is scored on a 4-point Likert scale.
|
12 months
|
|
Quality of life (informal caregiver)
Time Frame: 24 months
|
Quality of life of informal caregivers measured by the Investigating Choice Experiments for the Preferences of Older People CAPability measure for Older people (ICECAP-O) (Makai, 2015).
The questionnaire is scored on a 4-point Likert scale.
|
24 months
|
|
Quality of life (person with dementia)
Time Frame: 24 months
|
Quality of life of persons with dementia measured by the Quality of Life- Alzheimer's Disease scale (QOL-AD) (Logsdon et al., 2002).
The questionnaire is scored on a 4-point Likert scale.
|
24 months
|
|
Experienced burden of informal care
Time Frame: 12 months
|
Experienced burden of informal caregivers measured by the EDIZ ("Ervaren Druk door Informele Zorg" / experienced burden of informal care) (Pot, 1995).
The questionnaire is scored on a 5-point Likert scale.
|
12 months
|
|
Participant characteristics
Time Frame: baseline
|
Characteristics of the informal caregivers and persons with dementia collected by the TOPICS-MDS questionnaire to capture TOPICS-MDS:
|
baseline
|
|
Cognitive status of the person with dementia as estimated by the informal caregiver
Time Frame: baseline
|
Cognitive status of the person with dementia as estimated by the informal caregiver measured by a selection of the Quick Dementia Rating System (QDRS).
The questionnaire is scored on a 5-point Likert scale.
|
baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Marjolein de Vugt, professor, Maastricht University
Publications and helpful links
General Publications
- Boots LM, de Vugt ME, Withagen HE, Kempen GI, Verhey FR. Development and Initial Evaluation of the Web-Based Self-Management Program "Partner in Balance" for Family Caregivers of People With Early Stage Dementia: An Exploratory Mixed-Methods Study. JMIR Res Protoc. 2016 Mar 1;5(1):e33. doi: 10.2196/resprot.5142.
- Boots LM, de Vugt ME, Kempen GI, Verhey FR. Effectiveness of the blended care self-management program "Partner in Balance" for early-stage dementia caregivers: study protocol for a randomized controlled trial. Trials. 2016 May 4;17(1):231. doi: 10.1186/s13063-016-1351-z.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- METC 2021-2955
- 80-85200-98-21039 (Other Grant/Funding Number: ZonMw)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia, Mild
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
NYU Langone HealthRecruiting
-
Ludwig-Maximilians - University of MunichBayerisches Staatsministerium für Gesundheit, Pflege und PräventionRecruitingMild Cognitive Impairment | Mild DementiaGermany
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Dementia, Alzheimer Type | Dementia Alzheimers | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, MildUnited States
-
University Hospital, AngersBiomathicsUnknownHealthy | Mild Cognitive Impairment | Mild Dementia | Moderate DementiaFrance
-
Maastricht University Medical CenterRecruitingMild Cognitive Impairment | Mild Dementia | Amnestic Mild Cognitive DisorderNetherlands
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Mclean HospitalNational Institute on Aging (NIA)Active, not recruitingMild Cognitive Impairment | Mild Alzheimer DiseaseUnited States
-
Sunnybrook Health Sciences CentreSunnybrook Research InstituteRecruitingAlzheimer Disease | Alzheimer Dementia | Neurocognitive Disorder | Mild Cognitive Disorder | Alzheimer Dementia (AD) | Neurocognitive Disorders, Mild | Alzheimer s DiseaseCanada
Clinical Trials on Partner in Balance
-
Sygehus LillebaeltUniversity of Southern Denmark, Department of Regional Health ResearchRecruiting
-
Gallaudet UniversityNational Institute on Aging (NIA)Active, not recruitingFall | Old Age | Deaf | American Sign LanguageUnited States
-
Superior UniversityActive, not recruiting
-
Soroka University Medical CenterCompletedAging | DehydrationIsrael
-
Riphah International UniversityCompletedDiabetes Mellitus, Type 2Pakistan
-
Hasselt UniversityRecruitingDevelopment Coordination Disorder | Typical Developed ChildrenBelgium
-
Centers for Disease Control and PreventionTulane UniversityCompletedUrethritis | Trichomonas VaginalisUnited States
-
University of WashingtonUniversity of Nairobi; Kenya Ministry of HealthCompleted
-
University of ArizonaQatar National Research Foundation, QatarUnknown
-
Princess Amalia Children's ClinicCompleted